<DOC>
	<DOCNO>NCT01940692</DOCNO>
	<brief_summary>Through randomize control trial , compare intravenous administration tranexamic acid intra-articular application total hip arthroplasty direct anterior approach . - RCT , prospective study - Academic-monocentric study - Clinical outcome measurements The postoperative blood loss primary outcome . Secondary outcomes 1 . The rate perioperative postoperative blood transfusion 2 . The number blood unit transfuse 3 . The length hospital stay 4 . Perioperative give intravenous isotonic fluid The Null-hypothesis significant difference postoperative blood loss intra-articular intravenous administration TXA .</brief_summary>
	<brief_title>Topical Intravenous Administration TXA Are Equally Effective DAA THA</brief_title>
	<detailed_description>Study protocol : Topical application tranexamic acid compare intravenous administration total hip arthroplasty direct anterior approach A prospective , randomize , clinical trial Researchers : B. Jacobs Dr. S. Ghijselings Supervisors : Dr. R. Driesen , Dr. M. Beran , Dr. R. Heylen Co√∂rdinerend supervisor : Prof dr. K. Corten Background The prevalence total hip arthroplasty ( THA ) increase accompany blood loss overlook . In 2007 , 17,347 patient underwent THA Belgium number grows every year average 2.9 % . The average amount blood loss associate THA range 1000 2000mL . Therefore substantial perioperative blood loss frequently necessitate blood transfusion . Although complication decrease , morbidity high cost due blood transfusion still exist . To avoid blood transfusion THA , tranexamic acid ( TXA ) administer . TXA , synthetic amino acid block lysine bind site plasminogen competitive way , antifibrinolytic agent . TXA administer intravenously intra-articular . The ideal method provide TXA remain topic debate . Several study proven intravenous application reduces blood loss need blood transfusion patient undergoing THA . In contrast , intravenous administration small percentage drug reach target location , rest distributes across whole body . Hence risk possible side effect intravenous administration , like thromboembolic event gastrointestinal complaint , theoretically great . Local application TXA could get around possible systemic side effect . The benefit topical application TXA proven dental surgery , cardiac surgery , spine surgery total knee arthroplasty . In case-control study , Van Elst et al ( 20 ) recently prove local application TXA THA reduce total bleed 100 380 mL comparison placebo . Null - Hypothesis In study , compare efficacy intra-articular application TXA intravenous administration term postoperative blood loss . Our hypothesis significant difference postoperative blood loss intra-articular intravenous administration TXA . Materials Methods What : - Power analysis - RCT , prospective study - Monocentric study - Clinical outcome measurement Each patient give write consent inclusion study . This prospective , single-centered , randomized clinical trial design enroll total 120 patient meet inclusion criterion , approximate 60 patient group . Patients allocate ) intravenous application TXA b ) intra-articular administration TXA , use computer-generated randomization table . Inclusion criterion : All adult ( patient age eighteen year ) schedule primary unilateral total hip arthroplasty due osteoarthritis Ziekenhuis Oost-Limburg , Genk , Belgium eligible inclusion study . Exclusion criterion : A patient exclude study history coagulopathy , allergy tranexamic acid , preoperative anemia , fibrinolytic disorder , history arterial venous thromboembolic disease , disturbances color vision , pregnancy , breastfeeding , major comorbidities participation another clinical trial . Preoperative protocol With blood sample , preoperative hemoglobin level measure . This hemoglobin level use calculate postoperative blood loss . Surgical procedure Spinal anesthesia give patient standard monitoring use surgery . Two orthopedic surgeon ( K.C . R.D . ) participate study . Both surgeon use surgical technique , direct anterior approach ( DAA ) . The type prosthesis use base surgeon 's preference patient age , activity level demand . All implant cementless surgical drain place collect postoperative blood loss . Whenever intraoperative surgical , medical , anesthetic complication occur , TXA administer patient exclude study . Prophylaxis antibiotic , 2g cephalosporin , intravenously administer right intervention repeat three time within 24 hour constant time interval . Tranexamic acid procedure To ensure double-blinding upset study , 60 patient control group receive solution 1.5g TXA 100ml 0.9 % NaCl , administer intravenously closure incision . A dose 3g TXA apply intra-articular group 60 patient . The intra-articular injection apply THA , wound already close . Two hour wound closing , surgical drain open . The two hour wait wound close proven successful . Postoperative follow-up Postoperative apply prophylaxis early mobilization use prevent deep-vein thrombosis ( DVT ) . The administered prophylaxis include daily low molecular weight heparin six week surgery . While hospital , patient examine daily clinical symptom DVT . Patients also receive compressive stocking wear surgery . Postoperative hemoglobin level measure first fourth day postoperative . All patient remain hospital minimum 5 day . Outcome measure The primary outcome postoperative blood loss . The difference total blood loss intraoperative blood loss use predict postoperative blood loss patient . The secondary outcome include : 1 . The rate perioperative postoperative blood transfusion 2 . The number blood unit transfuse 3 . The length hospital stay 4 . Perioperative give intravenous isotonic fluid The criterion transfusion blood product hemoglobin level &lt; 8.0 g/dL patient develop intolerable symptom anemia comorbidities may relate anemia attributable another cause ongoing blood loss occur . If transfusion necessary , amount unit pack red blood cell estimate accord hemoglobin level severity symptom intention increase hemoglobin level 8.0 g/dL . Statistical analysis Each patient receive detailed brochure information concern study procedure write informed consent obtain . Patients decline offer participation study . In case patient shall get treatment propose . Patients accept participate randomize either group intravenous administration intra-articular administration tranexamic acid . These patient receive number randomly assign either intravenous intra-articular group computer .</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Joint Diseases</mesh_term>
	<mesh_term>Tranexamic Acid</mesh_term>
	<criteria>All adult ( patient age eighteen year ) schedule primary unilateral total hip arthroplasty due osteoarthritis Ziekenhuis OostLimburg , Genk , Belgium eligible inclusion study . History coagulopathy Allergy tranexamic acid preoperative anemia fibrinolytic disorder history arterial venous thromboembolic disease disturbance color vision pregnancy breastfeed major comorbidities participation another clinical trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
</DOC>